Pages that link to "Q42160313"
Jump to navigation
Jump to search
The following pages link to Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes (Q42160313):
Displaying 41 items.
- Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cells (Q24321472) (← links)
- The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways (Q26824858) (← links)
- Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion (Q27485447) (← links)
- Amphiphysin I Antisense Oligonucleotides Inhibit Neurite Outgrowth in Cultured Hippocampal Neurons (Q30176317) (← links)
- Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus (Q33727061) (← links)
- A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion (Q33741229) (← links)
- Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism (Q33782576) (← links)
- Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance (Q34399523) (← links)
- Insulin-stimulated degradation of apolipoprotein B100: roles of class II phosphatidylinositol-3-kinase and autophagy (Q34629362) (← links)
- Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins (Q34634838) (← links)
- Acute suppression of apo B secretion by insulin occurs independently of MTP (Q34669545) (← links)
- Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. (Q35186665) (← links)
- Hepatic ABCA1 and VLDL triglyceride production (Q35737630) (← links)
- Hepatic regulation of apolipoprotein B. (Q35919242) (← links)
- Identification of two regions in apolipoprotein B100 that are exposed on the cytosolic side of the endoplasmic reticulum membrane (Q36255357) (← links)
- New insight into the pathophysiology of lipid abnormalities in type 2 diabetes (Q36343495) (← links)
- Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targeting (Q36532383) (← links)
- Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients (Q36843216) (← links)
- The physiological and molecular regulation of lipoprotein assembly and secretion (Q36911216) (← links)
- Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain (Q36930787) (← links)
- Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling (Q37408615) (← links)
- Hepatic ABC transporters and triglyceride metabolism. (Q38001336) (← links)
- Ectopic lipid storage and insulin resistance: a harmful relationship (Q38095619) (← links)
- The regulation of ApoB metabolism by insulin (Q38110665) (← links)
- Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases (Q39150236) (← links)
- Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions (Q39299548) (← links)
- Development of a 2-D apoB peptide profile to detect conformational changes associated with apoB-containing lipoproteins (Q39828221) (← links)
- Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation (Q40630837) (← links)
- Ubiquitin-proteasome-dependent degradation of apolipoprotein B100 in vitro (Q40975614) (← links)
- Suppression of the Protein Tyrosine Phosphatase LAR Reduces Apolipoprotein B Secretion by McA-RH7777 Rat Hepatoma Cells (Q41093550) (← links)
- Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins. (Q41885419) (← links)
- Phosphoinositide 3-Kinase Activity Is Necessary for Insulin-dependent Inhibition of Apolipoprotein B Secretion by Rat Hepatocytes and Localizes to the Endoplasmic Reticulum (Q42447707) (← links)
- Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor (Q42525782) (← links)
- Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance (Q43764679) (← links)
- The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment: evidence for multiple redundant pathways (Q44897914) (← links)
- Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia (Q46703453) (← links)
- Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles (Q51031951) (← links)
- Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production (Q51553010) (← links)
- A common apolipoprotein B signal peptide polymorphism modifies the relation between plasma non-esterified fatty acids and triglyceride concentration in men. (Q51553688) (← links)
- The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes (Q51565752) (← links)
- PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice (Q51798503) (← links)